Brief: Oncosil Medical Says Proposes To Undertake Non-Renounceable Entitlement Offer
20/03/2024 01:28
March 20 (Reuters) - Oncosil Medical OSL.AX :
* PROPOSES TO UNDERTAKE NON-RENOUNCEABLE ENTITLEMENT OFFER
TO
RAISE UP TO MAXIMUM OF A$5.65 MILLION
* PLACEMENT & ENTITLEMENT OFFER TO RAISE A$7.1 MILLION
* PLACEMENT AT ISSUE PRICE OF A$0.005 PER NEW SHARE
* ENTITLEMENT OFFER AT SAME ISSUE PRICE AS PLACEMENT
Further company coverage: OSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncosil Medical
See all newsAustralia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval